Clinical Trial Update: Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study of rIX-FP (recombinant factor IX albumin fusion protein) in Chinese subjects with Hemophilia B. The trial is active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rIX-FP (recombinant coagulation factor IX albumin fusion protein)

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia B | Phase 3 | Status: ACTIVE_NOT_RECRUITING